Anika Therapeutics (ANIK) Director Gary Fischetti Receives RSU Award

What Happened

• Gary P. Fischetti, a director of Anika Therapeutics, received an award of 10,402 restricted stock units (RSUs) on 2026-06-18. The RSUs were granted at $0.00 (no purchase price), representing a contingent right to receive one share of common stock per RSU when they vest. This is a compensation award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-18; Form 4 filed: 2026-06-23 (filed one business day late vs. the two-business-day reporting requirement).
• Grant: 10,402 RSUs; grant price reported as $0.00.
• Shares owned after the transaction: not specified in the filing.
• Footnote: Each RSU equals a contingent right to one share. The RSUs vest in full on the earlier of the Company's 2027 annual meeting or June 18, 2027.
• Transaction type: A = Award/Grant.

Context

• RSU grants are common director/executive compensation and do not represent an immediate cash investment or sale; value is realized only if and when RSUs vest and convert to shares.
• Because this was an award rather than a purchase or sale, it shouldn't be interpreted directly as a bullish or bearish market signal. The filing was submitted after the two-business-day deadline (late by one business day), which can matter for timeliness transparency.